Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 1,724 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AIMS Clear all

Conditions: Attention Deficit Hyperactivity Disorder Symptoms
Interventions: Positive Behavior Management Toolkit; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Myelodysplastic Syndromes
Interventions: High-dose ascorbate, Azacitidine; Drug
Lead sponsor: Prajwal Dhakal; Other
Eligibility: 18 Years to 99 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Bottle Feeding
Interventions: Digital Health Intervention, Safety Control; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older · Female only
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sexual Dysfunction, Breast Cancer, Prostate Cancer
Interventions: Sensate Focus exercise; Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: Non-Small Cell Lung Cancer
Interventions: Adjuvant Chemotherapy, Radiographic surveillance, 14-Gene Prognostic Assay; Drug · Other
Lead sponsor: Razor Genomics; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 18
States / cities: Mission Viejo, California • Sacramento, California • Santa Rosa, California + 15 more

Conditions: Hiv, Chlamydia, Gonorrhea, Relation, Interpersonal
Interventions: 2GETHER, Positive Affect Enhancement; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Polycythemia Vera
Interventions: Givinostat, Hydroxyurea; Drug
Lead sponsor: Italfarmaco; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 14
States / cities: Birmingham, Alabama • Redlands, California • Englewood, Colorado + 10 more

Conditions: Non-Small Cell Lung Cancer
Interventions: Osimertinib, Savolitinib, Gefitinib, Necitumumab, Durvalumab, Carboplatin, Pemetrexed, Alectinib, Selpercatinib, Selumetinib, Etoposide, Cisplatin, Datopotamab deruxtecan; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 16
States / cities: Duarte, California • Los Angeles, California • Sacramento, California + 11 more

Conditions: HIV/AIDS, STI, HCV
Interventions: Peer Navigation, mHealth; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Aging, Physical Dependence
Interventions: VIPA and companion booklet; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 65 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: ESRD
Interventions: anakinra, actos, placebo; Drug · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: HIV Infection Primary
Interventions: an adaptation of the iENGAGE; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Metabolic Syndrome
Interventions: muscle biopsy; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression, Drug Use
Interventions: Families with Pride ("Familias con Orgullo"); Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 13 Years to 19 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Childhood Obesity
Interventions: Not listed
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 3 Years to 4 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Suicide Prevention
Interventions: Cognitive Reappraisal Intervention for Suicide Prevention, Supportive Therapy; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Depressive Disorder, Major
Interventions: Cognitive Therapy (CT) for depression, Cognitive Therapy (CT) for depression + Memory Support; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Friedreich Ataxia
Interventions: Buccal Swabs and Blood Draws; Diagnostic Test
Lead sponsor: Larimar Therapeutics, Inc.; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 20 participants
Timeline: 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Medication Adherence
Interventions: Pharmacist-led, technology enabled education intervention; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Chronic Pain
Interventions: Mindfulness-Based Cognitive Therapy for Trauma-Informed Pain (MBCT-TIP), Health Enhancement Program (HEP); Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Major Depressive Disorder
Interventions: Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed Cognitive Remediation plus Bridging); Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Dementia, Alzheimer Disease
Interventions: Isle of TEND Intervention; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Head and Neck Cancer, Patients Requiring a Free Flap Surgery
Interventions: FloTrac; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Opioid Use Disorder
Interventions: Medication for opioid use disorder, psychotherapy; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2030
U.S. locations: 1
States / cities: Irvine, California

Search by objective public record fields.

Implementation Strategy Resource Package for Behavioral Classroom Interventions: Pilot Test

Ascorbate in Myelodysplastic Syndrome

GrowWell - Responsive Bottle Feeding

An Intimacy Intervention for Couples Completing Breast or Prostate Cancer

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Appalachian Partnership to Reduce Disparities (Aim 2)

Intelligent Personal Assistant for Managing Depression in Homebound Older Adults

Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2

Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes

Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome

Families With Pride ("Familias Con Orgullo").

Physical Activity and Screen-Time Regulations in Childcare Centers - Aim 1

A Novel Cognitive Reappraisal Intervention for Suicide Prevention

Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?

A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

Mindfulness Therapy for Chronic Pain After Intimate Partner Violence

A Novel Cognitive Remediation Intervention Targeting Poor Decision-making and Depression in Veterans at High Risk for Suicide: A Safe, Telehealth Approach During the COVID-19 Pandemic

Toolkit for Experiential Well-beiNg in Dementia (TEND)

A Prospective Study Evaluating the Use of Intraoperative Stroke Volume Variation Via the FloTrac Device to Guide Fluid and Vasopressor Management in Head and Neck Free Flaps

Dynamic Treatment Regimes for Opioid Use Disorder